| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.3 | 2e-11 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.32 | 1e-08 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.27 | 1e-08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.23 | 1e-07 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.2 | 3e-05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.2 | 8e-05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.064 | 0.2 |